About Us

RxBio is an early stage company formed around novel and proprietary small-molecule technology developed at the University of Tennessee Health Science Center (UTHSC) in Memphis and licensed from the University of Tennessee Research Foundation (UTRF).


RxBio's technology platform is broadly based and includes:

• Radioprotectant / radiomitigator Technology
• Whole-Body Protection
• Gut Protection

• Other Technology (longer term)
  • Resistant-Cancer / Cancer-Metastasis Technology
  • Plaque-Blocking Technology